Pharmacology of a new phthaline (Lu 10-171), with specific 5-HT uptake inhibiting properties
- 1 January 1977
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 41 (2) , 153-162
- https://doi.org/10.1016/0014-2999(77)90204-7
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171Psychopharmacology, 1977
- The Contribution of Drug Research to Investigating the Nature of Endogenous Depression*Pharmacopsychiatry, 1976
- Indoleamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptylineClinical Pharmacology & Therapeutics, 1973
- Central 5-HTP decarboxylase inhibiting properties of Ro 4-4602 in relation to 5-HTP potentiation in miceEuropean Journal of Pharmacology, 1972
- Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: A biochemical classification?Psychopharmacology, 1971
- Further Pharmacological Studies of Bicyclic ThymolepticsActa Pharmacologica et Toxicologica, 1970
- Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,α-dimethyl-meta-tyramineEuropean Journal of Pharmacology, 1969
- Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethyl-meta-tyramineEuropean Journal of Pharmacology, 1969
- Demonstration of extraneuronal 5-hydroxytryptamine accumulation in brain following membrane-pump blockade by chlorimipramineBrain Research, 1969
- Pharmacological Studies of a New Series of Bicyclic ThymolepticsActa Pharmacologica et Toxicologica, 1966